AKITA UNIVERSITY HOSPITAL
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1971-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (66.7%)Phase 1
1 (33.3%)Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer
Phase 1
Suspended
- Conditions
- Bile Duct Cancer
- Interventions
- Biological: Peptide vaccine for URLC10
- First Posted Date
- 2008-02-26
- Last Posted Date
- 2015-06-23
- Lead Sponsor
- Akita University Hospital
- Target Recruit Count
- 9
- Registration Number
- NCT00624182
- Locations
- 🇯🇵
Akita University Hosipital, Akita, Japan
News
No news found